» Articles » PMID: 15315761

Mammalian Cells Cycle Without the D-type Cyclin-dependent Kinases Cdk4 and Cdk6

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2004 Aug 19
PMID 15315761
Citations 369
Authors
Affiliations
Soon will be listed here.
Abstract

Cdk4 and Cdk6 are thought to be essential for initiation of the cell cycle in response to mitogenic stimuli. Previous studies have shown that Cdk4 is dispensable for proliferation in most cell types, an observation attributed to a putative compensatory role by Cdk6. Cdk6-null mice are viable and develop normally although hematopoiesis is slightly impaired. Embryos defective for Cdk4 and Cdk6 die during the late stages of embryonic development due to severe anemia. However, these embryos display normal organogenesis and most cell types proliferate normally. In vitro, embryonic fibroblasts lacking Cdk4 and Cdk6 proliferate and become immortal upon serial passage. Moreover, quiescent Cdk4/Cdk6-null cells respond to serum stimulation and enter S phase with normal kinetics although with lower efficiency. These results indicate that D-type cyclin-dependent kinases are not essential for cell cycle entry and suggest the existence of alternative mechanisms to initiate cell proliferation upon mitogenic stimulation.

Citing Articles

CDK6-Dependent, CDK4-Independent Synovial Hyperplasia in Arthritic Mice and Tumor Necrosis Factor-α-Induced Proliferation of Synovial Fibroblasts.

Komatsu R, Fujii R, Ogasawara T, Suzuki-Takahashi Y, Chen S, Sugishita Y Int J Mol Sci. 2025; 26(3).

PMID: 39940918 PMC: 11817658. DOI: 10.3390/ijms26031151.


Targeting CDK4/6 in breast cancer.

Shanabag A, Armand J, Son E, Yang H Exp Mol Med. 2025; 57(2):312-322.

PMID: 39930131 PMC: 11873051. DOI: 10.1038/s12276-025-01395-3.


Cdk6's functions are critically regulated by its unique C-terminus.

Schirripa A, Schoppe H, Nebenfuehr S, Zojer M, Klampfl T, Kugler V iScience. 2025; 28(2):111697.

PMID: 39898030 PMC: 11787673. DOI: 10.1016/j.isci.2024.111697.


Targeting the mitotic kinase NEK2 enhances CDK4/6 inhibitor efficacy by potentiating genome instability.

Bobbitt J, Cuellar-Vite L, Weber-Bonk K, Yancey M, Majmudar P, Keri R J Biol Chem. 2025; 301(2):108196.

PMID: 39826695 PMC: 11849632. DOI: 10.1016/j.jbc.2025.108196.


Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.

Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N Signal Transduct Target Ther. 2025; 10(1):11.

PMID: 39800748 PMC: 11734941. DOI: 10.1038/s41392-024-02080-z.